Cargando…
Landiolol for managing atrial fibrillation in post-cardiac surgery
Landiolol is an intravenous ultra-short acting beta-blocker which has been used in Japan for many years to prevent and/or to treat post-operative atrial fibrillation following cardiac surgery. The drug is now available in Europe. This article is a systematic review of literature regarding the use of...
Autores principales: | Fellahi, Jean-Luc, Heringlake, Matthias, Knotzer, Johann, Fornier, William, Cazenave, Laure, Guarracino, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909770/ https://www.ncbi.nlm.nih.gov/pubmed/30188961 http://dx.doi.org/10.1093/eurheartj/sux038 |
Ejemplares similares
-
Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction
por: von Haehling, Stephan, et al.
Publicado: (2018) -
Landiolol for managing post-operative atrial fibrillation
por: Balik, Martin, et al.
Publicado: (2018) -
Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial
por: Caspersen, Edouard, et al.
Publicado: (2023) -
Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery
por: Fornier, William, et al.
Publicado: (2017) -
Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018)